Demographics of the women in the LeMS study (N=29)
| Variables | N (%) |
|---|---|
| Age (years) | |
| Mean age at MS onset | 23 years |
| Mean age at pregnancy onset | 26.6 years |
| Level of education | |
| High school | 21 (72.4) |
| Undergraduate | 8 (27.6) |
| Marital status | |
| Engaged | 8 (27.6) |
| Married | 21 (72.4) |
| Comorbidities | |
| Diabetes | 2 (6.9) |
| Hypertension | 3 (10.3) |
| MS lesions | |
| Brain | 29 (100) |
| Brain and cervical spine | 7 (24.1) |
| MS diagnosis | |
| MRI | 29 (100) |
| CSF and oligoclonal positive | 26 (89.7) |
| CSF and oligoclonal not performed | 3 (10.3) |
| Pregnancies after MS onset | |
| One | 4 (13.8) |
| Two | 15 (51.7) |
| Three | 10 (34.5) |
| Supplements taken during pregnancy | |
| Vitamin D3 | 21 (72.4) |
| Co-enzyme Q-10 | 20 (69) |
| Fluoxetine | 11 (37.9) |
| Magnesium sulfate | 21 (72.4) |
| Delivery method | |
| Normal vaginal | 23 (79.3) |
| Caesarean | 6 (20.7) |
| Epidural anaesthesia | 21 (72.4) |
| Length of breastfeeding (days) | |
| 21–35 | 6 (20.7) |
| 93–255 | 23 (79.3) |
| Treatment after pregnancy | |
| Resumed after 11–14 months | 22 (75.9) |
| Stopped indefinitely | 7 (24.1) |
CSF, cerebrospinal fluid; LeMS, the Lebanese Multiple Sclerosis study; MS, multiple sclerosis.